Skip to main content
Erschienen in: Neurotherapeutics 3/2016

01.07.2016 | Original Article

Neurological Dysfunction in Early Maturity of a Model for Niemann–Pick C1 Carrier Status

verfasst von: Ya Hui Hung, Mark Walterfang, Leonid Churilov, Lisa Bray, Laura H. Jacobson, Kevin J. Barnham, Nigel C. Jones, Terence J. O’Brien, Dennis Velakoulis, Ashley I. Bush

Erschienen in: Neurotherapeutics | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Autosomal recessive inheritance of NPC1 with loss-of-function mutations underlies Niemann–Pick disease, type C1 (NP-C1), a lysosomal storage disorder with progressive neurodegeneration. It is uncertain from limited biochemical studies and patient case reports whether NPC1 haploinsufficiency can cause a partial NP-C1 phenotype in carriers. In the present study, we examined this possibility in heterozygotes of a natural loss-of-function mutant Npc1 mouse model. We found partial motor dysfunction and increased anxiety-like behavior in Npc1 +/– mice by 9 weeks of age. Relative to Npc1 +/+ mice, Npc1 +/– mice failed to show neurodevelopmental improvements in motor coordination and balance on an accelerating Rotarod. In the open-field test, Npc1 +/– mice showed an intermediate phenotype in spontaneous locomotor activity compared with Npc1 +/+ and Npc1 –/– mice, as well as decreased center tendency. Together with increased stride length under anxiogenic conditions on the DigiGait treadmill, these findings are consistent with heightened anxiety. Our findings indicate that pathogenic NPC1 allele carriers, who represent about 0.66 % of humans, could be vulnerable to motor and anxiety disorders.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mengel E, Klunemann HH, Lourenco CM, et al. Niemann–Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis 2013;8:166. Mengel E, Klunemann HH, Lourenco CM, et al. Niemann–Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis 2013;8:166.
2.
Zurück zum Zitat Patterson MC, Hendriksz CJ, Walterfang M, et al. Recommendations for the diagnosis and management of Niemann–Pick disease type C: an update. Mol Genet Metab 2012;106:330-344. Patterson MC, Hendriksz CJ, Walterfang M, et al. Recommendations for the diagnosis and management of Niemann–Pick disease type C: an update. Mol Genet Metab 2012;106:330-344.
3.
Zurück zum Zitat Patterson MC, Mengel E, Wijburg FA, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 2013;8:12. Patterson MC, Mengel E, Wijburg FA, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis 2013;8:12.
4.
Zurück zum Zitat Love S, Bridges LR, Case CP. Neurofibrillary tangles in Niemann–Pick disease type C. Brain 1995;118:119-129. Love S, Bridges LR, Case CP. Neurofibrillary tangles in Niemann–Pick disease type C. Brain 1995;118:119-129.
5.
Zurück zum Zitat Ong WY, Kumar U, Switzer RC, et al. Neurodegeneration in Niemann–Pick type C disease mice. Exp Brain Res 2001;141:218-231. Ong WY, Kumar U, Switzer RC, et al. Neurodegeneration in Niemann–Pick type C disease mice. Exp Brain Res 2001;141:218-231.
6.
Zurück zum Zitat Yamada A, Saji M, Ukita Y, et al. Progressive neuronal loss in the ventral posterior lateral and medial nuclei of thalamus in Niemann–Pick disease type C mouse brain. Brain Dev 2001;23:288-297. Yamada A, Saji M, Ukita Y, et al. Progressive neuronal loss in the ventral posterior lateral and medial nuclei of thalamus in Niemann–Pick disease type C mouse brain. Brain Dev 2001;23:288-297.
7.
Zurück zum Zitat Yu T, Lieberman AP. Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin. PLoS Genet 2013;9:e1003462. Yu T, Lieberman AP. Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin. PLoS Genet 2013;9:e1003462.
8.
Zurück zum Zitat Vanier MT. Niemann–Pick disease type C. Orphanet J Rare Dis 2010;5:16. Vanier MT. Niemann–Pick disease type C. Orphanet J Rare Dis 2010;5:16.
9.
Zurück zum Zitat Patterson MC, Mengel E, Vanier MT, et al. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann–Pick disease type C: an observational cohort study. Orphanet J Rare Dis 2015;10:65. Patterson MC, Mengel E, Vanier MT, et al. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann–Pick disease type C: an observational cohort study. Orphanet J Rare Dis 2015;10:65.
10.
Zurück zum Zitat Wassif CA, Cross JL, Iben J, et al. High incidence of unrecognized visceral/neurological late-onset Niemann–Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med 2016;18:41-48. Wassif CA, Cross JL, Iben J, et al. High incidence of unrecognized visceral/neurological late-onset Niemann–Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med 2016;18:41-48.
11.
Zurück zum Zitat Kruth HS, Comly ME, Butler JD, et al. Type C Niemann–Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts. J Biol Chem 1986;261:16769-16774. Kruth HS, Comly ME, Butler JD, et al. Type C Niemann–Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts. J Biol Chem 1986;261:16769-16774.
12.
Zurück zum Zitat Brown DE, Thrall MA, Walkley SU, et al. Metabolic abnormalities in feline Niemann–Pick type C heterozygotes. J Inherit Metab Dis 1996;19:319-330. Brown DE, Thrall MA, Walkley SU, et al. Metabolic abnormalities in feline Niemann–Pick type C heterozygotes. J Inherit Metab Dis 1996;19:319-330.
13.
Zurück zum Zitat Choi HY, Karten B, Chan T, et al. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann–Pick type C disease. J Biol Chem 2003;278:32569-32577. Choi HY, Karten B, Chan T, et al. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann–Pick type C disease. J Biol Chem 2003;278:32569-32577.
14.
Zurück zum Zitat Porter FD, Scherrer DE, Lanier MH, et al. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann–Pick C1 disease. Sci Transl Med 2010;2:56ra81. Porter FD, Scherrer DE, Lanier MH, et al. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann–Pick C1 disease. Sci Transl Med 2010;2:56ra81.
15.
Zurück zum Zitat Garver WS, Jelinek D, Oyarzo JN, et al. Characterization of liver disease and lipid metabolism in the Niemann–Pick C1 mouse. J Cell Biochem 2007;101:498-516. Garver WS, Jelinek D, Oyarzo JN, et al. Characterization of liver disease and lipid metabolism in the Niemann–Pick C1 mouse. J Cell Biochem 2007;101:498-516.
16.
Zurück zum Zitat Jelinek D, Castillo JJ, Garver WS. The C57BL/6J Niemann-Pick C1 mouse model with decreased gene dosage has impaired glucose tolerance independent of body weight. Gene 2013;527:65-70. Jelinek D, Castillo JJ, Garver WS. The C57BL/6J Niemann-Pick C1 mouse model with decreased gene dosage has impaired glucose tolerance independent of body weight. Gene 2013;527:65-70.
17.
Zurück zum Zitat Jelinek D, Millward V, Birdi A, Trouard TP, Heidenreich RA, Garver WS. Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance. Hum Mol Genet 2011;20:312-321. Jelinek D, Millward V, Birdi A, Trouard TP, Heidenreich RA, Garver WS. Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance. Hum Mol Genet 2011;20:312-321.
18.
Zurück zum Zitat Meyre D, Delplanque J, Chevre JC, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009;41:157-159. Meyre D, Delplanque J, Chevre JC, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009;41:157-159.
19.
Zurück zum Zitat Yu W, Ko M, Yanagisawa K, Michikawa M. Neurodegeneration in heterozygous Niemann–Pick type C1 (NPC1) mouse: implication of heterozygous NPC1 mutations being a risk for tauopathy. J Biol Chem 2005;280:27296-27302. Yu W, Ko M, Yanagisawa K, Michikawa M. Neurodegeneration in heterozygous Niemann–Pick type C1 (NPC1) mouse: implication of heterozygous NPC1 mutations being a risk for tauopathy. J Biol Chem 2005;280:27296-27302.
20.
Zurück zum Zitat Josephs KA, Matsumoto JY, Lindor NM. Heterozygous Niemann–Pick disease type C presenting with tremor. Neurology 2004;63:2189-2190. Josephs KA, Matsumoto JY, Lindor NM. Heterozygous Niemann–Pick disease type C presenting with tremor. Neurology 2004;63:2189-2190.
21.
Zurück zum Zitat Kluenemann HH, Nutt JG, Davis MY, Bird TD. Parkinsonism syndrome in heterozygotes for Niemann-Pick C1. J Neurol Sci 2013;335:219-220. Kluenemann HH, Nutt JG, Davis MY, Bird TD. Parkinsonism syndrome in heterozygotes for Niemann-Pick C1. J Neurol Sci 2013;335:219-220.
22.
Zurück zum Zitat Harzer K, Beck-Wodl S, Bauer P. Niemann-pick disease type C: new aspects in a long published family—partial manifestations in heterozygotes. JIMD Rep 2014;12:25-29. Harzer K, Beck-Wodl S, Bauer P. Niemann-pick disease type C: new aspects in a long published family—partial manifestations in heterozygotes. JIMD Rep 2014;12:25-29.
23.
Zurück zum Zitat Bauer P, Balding DJ, Klunemann HH, et al. Genetic screening for Niemann–Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study. Hum Mol Genet 2013;22:4349-4356. Bauer P, Balding DJ, Klunemann HH, et al. Genetic screening for Niemann–Pick disease type C in adults with neurological and psychiatric symptoms: findings from the ZOOM study. Hum Mol Genet 2013;22:4349-4356.
24.
Zurück zum Zitat Loftus SK, Morris JA, Carstea ED, et al. Murine model of Niemann–Pick C disease: mutation in a cholesterol homeostasis gene. Science 1997;277:232-235. Loftus SK, Morris JA, Carstea ED, et al. Murine model of Niemann–Pick C disease: mutation in a cholesterol homeostasis gene. Science 1997;277:232-235.
25.
Zurück zum Zitat Jelinek D, Heidenreich RA, Erickson RP, Garver WS. Decreased Npc1 gene dosage in mice is associated with weight gain. Obesity (Silver Spring) 2010;18:1457-1459. Jelinek D, Heidenreich RA, Erickson RP, Garver WS. Decreased Npc1 gene dosage in mice is associated with weight gain. Obesity (Silver Spring) 2010;18:1457-1459.
26.
Zurück zum Zitat Jelinek DA, Maghsoodi B, Borbon IA, Hardwick RN, Cherrington NJ, Erickson RP. Genetic variation in the mouse model of Niemann Pick C1 affects female, as well as male, adiposity, and hepatic bile transporters but has indeterminate effects on caveolae. Gene 2012;491:128-134. Jelinek DA, Maghsoodi B, Borbon IA, Hardwick RN, Cherrington NJ, Erickson RP. Genetic variation in the mouse model of Niemann Pick C1 affects female, as well as male, adiposity, and hepatic bile transporters but has indeterminate effects on caveolae. Gene 2012;491:128-134.
27.
Zurück zum Zitat Voikar V, Rauvala H, Ikonen E. Cognitive deficit and development of motor impairment in a mouse model of Niemann–Pick type C disease. Behav Brain Res 2002;132:1-10. Voikar V, Rauvala H, Ikonen E. Cognitive deficit and development of motor impairment in a mouse model of Niemann–Pick type C disease. Behav Brain Res 2002;132:1-10.
28.
Zurück zum Zitat Belzung C. Measuring rodent exploratory behavior. In: Crusio WE, Gerlai RT (eds) Handbook of molecular-genetic techniques for brain and behavior research. 1st ed. Techniques in the behavioral and neural sciences, Vol. 13. Amsterdam. New York: Elsevier; 1999. p. xxvii, 965 p. Belzung C. Measuring rodent exploratory behavior. In: Crusio WE, Gerlai RT (eds) Handbook of molecular-genetic techniques for brain and behavior research. 1st ed. Techniques in the behavioral and neural sciences, Vol. 13. Amsterdam. New York: Elsevier; 1999. p. xxvii, 965 p.
29.
Zurück zum Zitat Hall C, Ballachey EL. A study of the rat's behavior in a field. A contribution to method in comparative psychology. Univ Calif Publ Psychol 1932;6:1-12. Hall C, Ballachey EL. A study of the rat's behavior in a field. A contribution to method in comparative psychology. Univ Calif Publ Psychol 1932;6:1-12.
30.
Zurück zum Zitat Sashindranath M, Daglas M, Medcalf RL. Evaluation of gait impairment in mice subjected to craniotomy and traumatic brain injury. Behav Brain Res 2015;286:33-38. Sashindranath M, Daglas M, Medcalf RL. Evaluation of gait impairment in mice subjected to craniotomy and traumatic brain injury. Behav Brain Res 2015;286:33-38.
31.
Zurück zum Zitat Pallier PN, Drew CJ, Morton AJ. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function. Brain Res Bull 2009;78:347-355. Pallier PN, Drew CJ, Morton AJ. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function. Brain Res Bull 2009;78:347-355.
32.
Zurück zum Zitat Lepicard EM, Venault P, Abourachid A, Pelle E, Chapouthier G, Gasc JP. Spatio-temporal analysis of locomotion in BALB/cByJ and C57BL/6J mice in different environmental conditions. Behav Brain Res 2006;167:365-372. Lepicard EM, Venault P, Abourachid A, Pelle E, Chapouthier G, Gasc JP. Spatio-temporal analysis of locomotion in BALB/cByJ and C57BL/6J mice in different environmental conditions. Behav Brain Res 2006;167:365-372.
33.
Zurück zum Zitat Crawley JN. What's Wrong With My Mouse?: Behavioral phenotyping of transgenic and knockout mice, 2nd ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2007. Crawley JN. What's Wrong With My Mouse?: Behavioral phenotyping of transgenic and knockout mice, 2nd ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2007.
34.
Zurück zum Zitat Amende I, Kale A, McCue S, Glazier S, Morgan JP, Hampton TG. Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J Neuroeng Rehab 2005;2:20. Amende I, Kale A, McCue S, Glazier S, Morgan JP, Hampton TG. Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J Neuroeng Rehab 2005;2:20.
35.
Zurück zum Zitat Hurlock EC, Bose M, Pierce G, Joho RH. Rescue of motor coordination by Purkinje cell-targeted restoration of Kv3.3 channels in Kcnc3-null mice requires Kcnc1. J Neurosci 2009;29:15735-15744. Hurlock EC, Bose M, Pierce G, Joho RH. Rescue of motor coordination by Purkinje cell-targeted restoration of Kv3.3 channels in Kcnc3-null mice requires Kcnc1. J Neurosci 2009;29:15735-15744.
36.
Zurück zum Zitat Bridenbaugh SA, Kressig RW. Laboratory review: the role of gait analysis in seniors' mobility and fall prevention. Gerontology 2011;57:256-264. Bridenbaugh SA, Kressig RW. Laboratory review: the role of gait analysis in seniors' mobility and fall prevention. Gerontology 2011;57:256-264.
37.
Zurück zum Zitat Walterfang M, Fietz M, Abel L, Bowman E, Mocellin R, Velakoulis D. Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann–Pick disease type C. J Inherit Metab Dis 2009;32(Suppl. 1):S221-S226. Walterfang M, Fietz M, Abel L, Bowman E, Mocellin R, Velakoulis D. Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann–Pick disease type C. J Inherit Metab Dis 2009;32(Suppl. 1):S221-S226.
38.
Zurück zum Zitat Walterfang M, Fietz M, Fahey M, et al. The neuropsychiatry of Niemann–Pick type C disease in adulthood. J Neuropsychiatry Clin Neurosci 2006;18:158-170. Walterfang M, Fietz M, Fahey M, et al. The neuropsychiatry of Niemann–Pick type C disease in adulthood. J Neuropsychiatry Clin Neurosci 2006;18:158-170.
39.
Zurück zum Zitat Roff CF, Strauss JF, 3rd, Goldin E, et al. The murine Niemann-Pick type C lesion affects testosterone production. Endocrinology 1993;133:2913-2923. Roff CF, Strauss JF, 3rd, Goldin E, et al. The murine Niemann-Pick type C lesion affects testosterone production. Endocrinology 1993;133:2913-2923.
40.
Zurück zum Zitat Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Parkinsonism among Gaucher disease carriers. J Med Genet 2004;41:937-940. Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Parkinsonism among Gaucher disease carriers. J Med Genet 2004;41:937-940.
41.
Zurück zum Zitat Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009;361:1651-1661. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009;361:1651-1661.
42.
Zurück zum Zitat Tayebi N, Callahan M, Madike V, et al. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 2001;73:313-321. Tayebi N, Callahan M, Madike V, et al. Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 2001;73:313-321.
43.
Zurück zum Zitat Erickson RP, Larson-Thome K, Weberg L, et al. Variation in NPC1, the gene encoding Niemann–Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population. Neurosci Lett 2008;447:153-157. Erickson RP, Larson-Thome K, Weberg L, et al. Variation in NPC1, the gene encoding Niemann–Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population. Neurosci Lett 2008;447:153-157.
44.
Zurück zum Zitat Borbon IA, Erickson RP. Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's. J Appl Genet 2011;52:213-218. Borbon IA, Erickson RP. Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's. J Appl Genet 2011;52:213-218.
Metadaten
Titel
Neurological Dysfunction in Early Maturity of a Model for Niemann–Pick C1 Carrier Status
verfasst von
Ya Hui Hung
Mark Walterfang
Leonid Churilov
Lisa Bray
Laura H. Jacobson
Kevin J. Barnham
Nigel C. Jones
Terence J. O’Brien
Dennis Velakoulis
Ashley I. Bush
Publikationsdatum
01.07.2016
Verlag
Springer US
Erschienen in
Neurotherapeutics / Ausgabe 3/2016
Print ISSN: 1933-7213
Elektronische ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-016-0427-5

Weitere Artikel der Ausgabe 3/2016

Neurotherapeutics 3/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.